Direktorat Registrasi ObatValid

FOSFOMYCIN DISODIUM

Claim this product
BPOM Number
GKL1933544044A1
Approved
25 June 2026
Expiry
23 March 2031
Form
SERBUK INJEKSI

About This Registration

FOSFOMYCIN DISODIUM is a BPOM-registered direktorat registrasi obat in Indonesia, registered under number GKL1933544044A1. Its current registration status is Valid, with the licence valid until 23 March 2031. The product is registered to NOVELL PHARMACEUTICAL LABORATORIES - INDONESIA. BPOM first approved this registration in May 2026. All registration data is sourced directly from the official BPOM public database and updated daily.

Registration data updated by BPOM

This product's registration details were changed on 2 July 2026. This may reflect a status change, renewal, or correction by BPOM.

Registration Details

Application
newaero
Packaging
DUS, 1 VIAL @ 2 G
Department
Direktorat Registrasi Obat
Data Last Updated
2 July 2026

Retail Audit Service

Get detailed market intelligence for this product across Indonesian retail channels

Multiple cities available
Custom questionnaires
Professional shoppers
Detailed reporting
Starting from $50 per city
What's included in the audit service?

Stock availability and positioning verification

Price checking and competitor analysis

Display quality and promotional material assessment

Store condition and customer experience evaluation

Custom questions tailored to your research needs

Professional photographs and detailed reports

Registered Owners

Ingredients (2)

KOMBINASI-FOSFOMYCIN SODIUM STERILE MIXTURE WITH SUCCINIC ACIDFOSFOMYCIN SODIUM

Market Intelligence

Owner Portfolio
NOVELL PHARMACEUTICAL LABORATORIES - INDONESIA holds 567 BPOM registrations
Manufacturer Scale
NOVELL PHARMACEUTICAL LABORATORIES - INDONESIA produces 567 registered products
Registration Age
Registered for 4 months
Update Status
Recently updated (90 days ago)

FDA Cross-Reference

via openFDA
Generic Name
FOSFOMYCIN TROMETHAMINE
Product Type
HUMAN PRESCRIPTION DRUG
Route of Administration
ORAL

Data sourced from the U.S. FDA drug label database (openFDA). May not exactly match this product variant.

Is this your product?

Claim it to manage registration, track renewals, and get expiry alerts.

Claim Product

More products from NOVELL PHARMACEUTICAL LABORATORIES - INDONESIA

ISONEST

-DKL1833542868A1
Valid
Approved: Apr 10, 2026CAIRAN INHALASI
View product →

BISOPROLOL FUMARATE

-GKL2633516517D1
Valid
Approved: May 29, 2026TABLET SALUT SELAPUT
View product →

BETAHISTINE HYDROCHLORIDE

-GKL1933545310A1
Valid
Approved: May 20, 2026TABLET
View product →

PREGABALIN

-GKL1533533601A1
Valid
Approved: Apr 20, 2026KAPSUL
View product →

ENTECAVIR

-GKL2633561017A1
Valid
Approved: Apr 27, 2026TABLET SALUT SELAPUT
View product →

Products in the same class

STAMOTENS 10

-DKL1019615410B1
Valid
Approved: Sep 5, 2026TABLET
PERTIWI AGUNG - INDONESIA
View product →

ACIFAR

-DKL9909209929A1
Valid
Approved: Jun 20, 2026KRIM
IFARS PHARMACEUTICAL LABORATORIES - INDONESIA
View product →

CYCLOGYNON

-DKL0526111316A1
Valid
Approved: May 20, 2026TABLET SALUT GULA
TUNGGAL IDAMAN ABDI - INDONESIA
View product →

RELAXON

-DKL1606317217A1
Valid
Approved: Feb 23, 2026TABLET SALUT SELAPUT
ERLANGGA EDI LABORATORIES (ERELA) - INDONESIA
View product →

DIPASOLON 4

-DKL1602505510A1
Valid
Approved: Oct 8, 2025TABLET
DIPA PHARMALAB INTERSAINS - INDONESIA
View product →
1